Trelagliptin Succinate: A Weekly Solution for Type 2 Diabetes
Experience improved glycemic control with our innovative once-weekly DPP-4 inhibitor.
Get a Quote & SampleProduct Core Value

Trelagliptin Succinate
Trelagliptin Succinate is a highly selective, long-acting dipeptidyl peptidase-4 (DPP-4) inhibitor, designed to offer a convenient once-weekly dosing regimen for patients with Type 2 Diabetes Mellitus (T2DM). It works by enhancing the body's own incretin system, leading to improved insulin secretion and reduced glucagon release in a glucose-dependent manner. This dual action helps to effectively manage blood glucose levels, reduce glycemic variability, and contribute to better overall diabetes control.
- Understanding how Trelagliptin works is key to its efficacy; it inhibits the DPP-4 enzyme, prolonging incretin activity to control blood sugar.
- For Type 2 Diabetes management, Trelagliptin Succinate offers a significant advantage with its once-weekly dosing, improving patient adherence.
- The benefits of Trelagliptin Succinate extend to reducing cholesterol and low-density lipoprotein levels, alongside improving islet cell activity.
- This innovative oral hypoglycemic agent aids in achieving better glycemic control, making it a valuable tool for endocrinologists.
Product Advantages
Enhanced Patient Compliance
The once-weekly dosing of Trelagliptin Succinate is a major advantage for Type 2 Diabetes management, significantly improving medication adherence compared to daily regimens.
Effective Glycemic Control
By effectively targeting DPP-4, Trelagliptin Succinate helps lower HbA1c levels and reduce daily blood glucose fluctuations, contributing to better overall glycemic control.
Improved Metabolic Profile
Beyond its primary function, Trelagliptin Succinate also demonstrates benefits in reducing cholesterol and low-density lipoprotein (LDL) levels, supporting a healthier metabolic profile.
Key Applications
Type 2 Diabetes Mellitus Treatment
This is the primary indication for Trelagliptin Succinate, where its DPP-4 inhibitory action aids in managing blood glucose levels.
Glycemic Variability Reduction
By prolonging incretin activity, Trelagliptin Succinate helps to smooth out daily blood glucose fluctuations, a crucial aspect of diabetes care.
Adjunct Therapy
It can be used as an add-on treatment when other therapies like metformin are not sufficient to reach glycemic goals.
Cholesterol Management Support
The positive impact on cholesterol and LDL levels makes it a supportive agent for patients managing multiple cardiovascular risk factors associated with T2DM.